ARWEN is a platform for RWE projects. Alongside projects initiated by ARWEN partners, our team provides research tracks with structured study protocols around high-impact therapeutic areas to drive informed decisions where patients need it the most. All the partner hospitals can join the research tracks with sponsored grants.

Review without commitment our study protocols
for the open studies.

Oncology – Solid tumors

Breast cancer

Evaluate and compare the treatment pathways of eBC HER2- patients

Lung cancer

Oncology – Liquid tumors

Acute myeloid leukemia

Evaluate treatment pathways in AML and efficacy of novel therapies

Chronic myeloid leukemia


Atopic dermatitis & psoriasis

Drug survival of antibody treatment in psoriasis and AD

the network for forward thinking healthcare providers

ARWEN is powered by